Clinical Trials Browser

Phase 3 × peginterferon alfa-2b × Gastrointestinal × Clear all

NCT00759109 2017-04-07

Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)

Phase 3 Completed

150 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular